UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043805
Receipt number R000050003
Scientific Title Preliminary study about the association of the quality improvement of the sleep and health status
Date of disclosure of the study information 2021/04/01
Last modified on 2021/04/01 16:40:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preliminary study about the association of the quality improvement of the sleep and health status

Acronym

Preliminary study about the association of the quality improvement of the sleep and health status

Scientific Title

Preliminary study about the association of the quality improvement of the sleep and health status

Scientific Title:Acronym

Preliminary study about the association of the quality improvement of the sleep and health status

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To inspect influence on health by the improvement of the quality of the sleep by using a sleep improvement program together with a health food for 12 weeks

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Quality of the sleep by the sleep improvement program (awake time, deep sleep %)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of test food daily intake, for 12 weeks.
Participate in a sleep improvement program for 12 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Subjects who agree in writing to study participation and can inspect on predetermined inspection day
(2) Subjects who are smartphone user, and use the bedclothing to get sleep data

Key exclusion criteria

(1) Subjects who were under treatment or have a history of serious diseases(e.g., diabetes, liver disease, kidney disease, or heart disease)
(2) Subjects who have a disease that requires constant medication, subjects with serious diseases that require medication, and subjects who have history
(3) Subjects who have history of mental illness (depression, etc.), chronic fatigue syndrome, insomnia, hypersomnia, circadian rhythm sleep disorder, parasomnia, etc
(4) Subjects who are under treatment of sleep apnea syndrome
(5) Subjects who are judged as unsuitable for the use environment based on the results of sleep improvement program
(6) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(7) Subjects who have experienced abnormal clinical test values or cardiopulmonary function and have been judged to have problems participating in the study
(8) Subjects at risk of developing allergy in relation to the study
(9) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
(10) Subjects who have participated in other clinical study within the last one month prior to the current study
(11) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating
(12) Subjects who are judged as unsuitable for the study by the investigator for other reason

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Mihoko
Middle name
Last name Kurokawa

Organization

Q'SAI CO., LTD.

Division name

Research and Development Department

Zip code

810-8588

Address

1-1-1 Yakuin, Chuo-ku, Fukuoka-shi, Japan

TEL

092-724-0855

Email

kurokawa@kyusai.co.jp


Public contact

Name of contact person

1st name Saki
Middle name
Last name Fukuchi

Organization

EP Mediate Co., Ltd.

Division name

Development Business Headquarters, TTC Center, Trial Planning Department

Zip code

162-0822

Address

Turuya Bldg.,2-23, Shimomiyabicho, Shinjuku-ku, Tokyo

TEL

03-5657-4983

Homepage URL


Email

fukuchi473@eps.co.jp


Sponsor or person

Institute

EP Mediate Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

non-disclosure

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Haradoi hospital

Address

6-40-8 Aoba, Higashi-ku, Fukuoka-shi, Fukuoka

Tel

092-691-3881

Email

irb@haradoi-hospital.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 01 Month 19 Day

Date of IRB

2021 Year 01 Month 19 Day

Anticipated trial start date

2021 Year 01 Month 26 Day

Last follow-up date

2021 Year 09 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 04 Month 01 Day

Last modified on

2021 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050003


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name